UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016141
Receipt number R000018724
Scientific Title Subtype Classification Consortium for Esophageal Squamous cell carcinoma Sensitivity
Date of disclosure of the study information 2015/03/01
Last modified on 2018/01/08 14:07:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Subtype Classification Consortium for Esophageal Squamous cell carcinoma Sensitivity

Acronym

SUCCESS study

Scientific Title

Subtype Classification Consortium for Esophageal Squamous cell carcinoma Sensitivity

Scientific Title:Acronym

SUCCESS study

Region

Japan


Condition

Condition

Esophageal cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To do subtype classification of esophageal cancer by profiling the gene expression of pretreatment biopsy sample

Basic objectives2

Others

Basic objectives -Others

Prospective cohort study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Subtype classification of esophageal cancer

Key secondary outcomes

Correlation between subtype classification and curative effects


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Patients was diagnosed newly with esophageal cancer, and will undergo a surgical treatment, radiotherapy or chemoradiotherapy.
2)Patients aged >= 20 years.
3)Written informed consent.

Key exclusion criteria

1)Patients have received systemic chemotherapy.
2)Patients have undergone chest and mediastinum radiotherapy.
3)Patients have HBs antigen or HCV antibody
4)Patients is taking an antiplatelet agent or anticoagulant agent
5)Patients have too small esophageal cancer
6)Patients are pregnant or lactating women.
7)Patients are not suitable for this study.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Manabu Muto

Organization

Kyoto university hospital

Division name

Clinical Oncology

Zip code


Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan

TEL

075-751-4592

Email

mmuto@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yusuke Amanuma

Organization

Kyoto university hospital

Division name

Clinical Oncology

Zip code


Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan

TEL

075-751-3518

Homepage URL


Email

yusuke12@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto university hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都大学医学部附属病院(京都府)、国立がん研究センター研究所(東京都)、近畿大学医学部附属病院(大阪府)、川崎医科大学附属病院(岡山県)、大阪府立成人病センター(大阪府)、長崎大学病院(長崎県)、国立がん研究センター東病院(千葉県)、北里大学病院(神奈川県)、富山大学附属病院(富山県)、千葉県がんセンター(千葉県)、石川県立中央病院(石川県)


Other administrative information

Date of disclosure of the study information

2015 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2014 Year 12 Month 17 Day

Date of IRB


Anticipated trial start date

2015 Year 03 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A multicenter prospective observational study


Management information

Registered date

2015 Year 01 Month 06 Day

Last modified on

2018 Year 01 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018724


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name